A citation-based method for searching scientific literature

Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda, Manabu Minami, Atsushi Kawaguchi, Toshinori Murayama, Masashi Kanai, Yukiko Mori, Shigemi Matsumoto, Shunsuke Chikuma, Noriomi Matsumura, Kaoru Abiko, Tsukasa Baba, Ken Yamaguchi, Akihiko Ueda, Yuko Hosoe, Satoshi Morita, Masayuki Yokode, Akira Shimizu, Tasuku Honjo, Ikuo Konishi. J Clin Oncol 2015
Times Cited: 606



Eleonora Ghisoni, Martina Imbimbo, Stefan Zimmermann, Giorgio Valabrega. Int J Mol Sci 2019
Times Cited: 57




List of shared articles



Times cited

Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer.
Shuang Zhang, Sonia Iyer, Hao Ran, Igor Dolgalev, Shengqing Gu, Wei Wei, Connor J R Foster, Cynthia A Loomis, Narciso Olvera, Fanny Dao,[...]. Cancer Discov 2021
8


Prognostic value of immune-related cells and genes in the tumor microenvironment of ovarian cancer, especially CST4.
Shuang Wang, Caixia Wang, Ouxuan Liu, Yuexin Hu, Xiao Li, Bei Lin. Life Sci 2021
0

T-Cell Receptor Therapy in the Treatment of Ovarian Cancer: A Mini Review.
Jessica W Y Wu, Sudiksha Dand, Lachlan Doig, Anthony T Papenfuss, Clare L Scott, Gwo Ho, Joshua D Ooi. Front Immunol 2021
0

The Complement System in Ovarian Cancer: An Underexplored Old Path.
Yaiza Senent, Daniel Ajona, Antonio González-Martín, Ruben Pio, Beatriz Tavira. Cancers (Basel) 2021
0

Immune checkpoint inhibitors in ovarian cancer: where do we stand?
Alexandra Leary, David Tan, Jonathan Ledermann. Ther Adv Med Oncol 2021
0

Application of Immunoprofiling Using Multiplexed Immunofluorescence Staining Identifies the Prognosis of Patients with High-Grade Serous Ovarian Cancer.
Shin-Wha Lee, Ha-Young Lee, Sung Wan Kang, Min Je Kim, Young-Jae Lee, Chang Ohk Sung, Yong-Man Kim. Int J Mol Sci 2021
0

Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer.
Xin Luo, Jing Xu, Jianhua Yu, Ping Yi. Front Immunol 2021
2